-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Lomond Therapeutics Holdings, Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q4 2021 to Q3 2024.
- Lomond Therapeutics Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$11K, a 0.76% decline year-over-year.
- Lomond Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$17.1M.
- Lomond Therapeutics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.94M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)